When HPV type 16 is detected in the oral cavity, patients are 22 times more likely to develop oropharyngeal cancers than those without HPV 16, according to researchers at Albert Einstein College of Medicine in New York City (JAMA Oncol 2016 Jan 21. [Epub ahead of print]).
